Do you want to read an article? Please log in or register.
The Freiburg Index of Post-TIPS Survival (FIPS) identifies patients at risk for further decompensation and ACLF after TIPS
Hepatology
Indications
Related content
Inflammatory Bowel Disease
Early intestinal ultrasound in severe ulcerative colitis identifies patients at increased risk of 1-year treatment failure and colectomy
J Crohns Colitis
Ilvemark JFKF, Wilkens R, Thielsen P, Dige A, Boysen T, Brynskov J, Bjerrum JT, Seidelin JB
doi: 10.1093/ecco-jcc/jjae101
Hepatology
Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis
J Hepatol
Fortea JI, Alvarado-Tapias E, Simbrunner B, Ezcurra I, Hernández-Gea V, Aracil C, Llop E, Puente A, Roig C, Reiberger T, García-Pagan JC, Calleja JL, Ferrero-Gregori A, Mandorfer M, Villanueva C, Crespo J
doi: 10.1016/j.jhep.2024.12.017
Gastrointestinal Cancer
Reliable Performance of mALBI Grade-Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First-Line Treatment: Comparative Analysis of 13 Risk Models
J Gastroenterol Hepatol
Hatanaka T, Kakizaki S, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Toyoda H, Ogawa C, Nishikawa H, Nishimura T, Kawata K, Kosaka H, Naganuma A, Yata Y, Ohama H, Kuroda H, Matono T, Tanaka K, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Kumada T, Real‐life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
doi: 10.1111/jgh.16871
Hepatology
Long-term outcome following liver transplantation of patients with ACLF grade 3
J Hepatol
Artru F, Sacleux SC, Ursic-Bedoya J, Ntandja Wandji LC, Lutu A, L'Hermite S, Levy C, Khaldi M, Levesque E, Dharancy S, Boleslawski E, Lebuffe G, Le Goffic C, Ichai P, Coilly A, De Martin E, Vibert E, Meszaros M, Herrerro A, Monet C, Jaber S, Samuel D, Mathurin P, Labreuche J, Pageaux GP, Saliba F, Louvet A
doi: 10.1016/j.jhep.2024.06.039
Gastrointestinal Cancer
Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy
Eur J Cancer
Cabrit N, Cheugoua-Zanetsie M, Tierney J, Thirion P, Nankivell M, Winter K, Yang H, Wijnhoven B, Vernerey D, Smithers BM, Piessen G, Nilsson M, Boonstra J, Ychou M, Law S, Cunningham D, Vathaire F, Stahl M, Urba S, Valmasoni M, Williaume D, Thomas J, Lordick F, Tepper J, Gebski V, Burmeister B, Paoletti X, Sandick JV, Fu J, Pignon JP, Ducreux M, Faron M, Michiels S, MANATEC-02 collaborative group
doi: 10.1016/j.ejca.2025.115292
Hepatology
Early occurrence of hepatic encephalopathy following TIPS-insertion is linked to impaired survival: a multicenter cohort study
Clin Gastroenterol Hepatol
Kabelitz MA, Sandmann L, Praktiknjo M, Mauz JB, Auer TA, Bruns T, Chang J, Fehrenbach U, Hinrichs J, Jansen C, Klöckner R, Kluwe J, Köhler M, Meyer C, Piecha F, Pollmanns MR, Ripoll C, Schultheiss M, Seifert LL, Stöhr F, Sturm L, Trebicka J, Zipprich A, Labenz C, Bettinger D, Maasoumy B, German Cirrhosis Study Group
doi: 10.1016/j.cgh.2025.01.024
Hepatology
Impact of first and further decompensation in patients with compensated ACLD due to MASLD
J Hepatol
Pennisi G, Di Maria G, Wai-Sun Wong V, de Ledinghen V, Sebastiani G, Viganò M, Fracanzani AL, Miele L, Bugianesi E, Ekstedt M, D'Ambrosio R, Ravaioli F, Schepis F, Marra F, Aghemo A, Svegliati-Baroni G, Persico M, Valenti L, Berzigotti A, George J, Armandi A, Nasr P, Kechagias S, Liguori A, Saltini D, Mendoza YP, Calvaruso V, Enea M, Lin H, Infantino G, Masarone M, Pugliese N, Tulone A, Di Marco V, Cammà C, Petta S
doi: 10.1016/j.jhep.2025.06.014
Gastritis
Hispanic/Latino Ethnicity is an Independent Predictor of Worse Survival for Gastric Cancer in a Multicenter Safety-Net Patient Population
Cancer Epidemiol Biomarkers Prev
Klingbeil KD, Dillon DL, Zarrinkhoo E, Bechay K, Park JY, Rook JM, Mederos MA, Girgis MD, Chen K, Chen KT, Bastani R, Manouchehr-Pour S, Dubé P, Viragh K, Thomas M, Chiu V, Kadera BE
doi: 10.1158/1055-9965.EPI-23-1224
Hepatology
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study
Lancet Gastroenterol Hepatol
Patidar KR, Ma AT, Juanola A, Barone A, Incicco S, Kulkarni AV, Hernández JLP, Wentworth B, Asrani SK, Alessandria C, Abdelkader NA, Wong YJ, Xie Q, Pyrsopoulos NT, Kim SE, Fouad Y, Torre A, Cerda E, Ferrer JD, Maiwall R, Simonetto DA, Papp M, Orman ES, Perricone G, Solé C, Lange CM, Farias AQ, Pereira G, Gadano A, Caraceni P, Thevenot T, Verma N, Kim JH, Vorobioff JD, Cordova-Gallardo J, Ivashkin V, Roblero JP, Maan R, Toledo C, Gioia S, Fassio E, Marino M, Nabilou P, Vargas V, Merli M, Goncalves LL, Rabinowich L, Krag A, Balcar L, Montes P, Mattos AZ, Bruns T, Mohammed A, Laleman W, Carrera E, Cabrera MC, Girala M, Samant H, Raevens S, Madaleno J, Kim RW, Arab JP, Presa J, Ferreira CN, Galante A, Allegretti AS, Takkenberg B, Marciano S, Sarin SK, Durand F, Ginès P, Angeli P, Solà E, Piano S, International Club of Ascites GLOBAL AKI team
doi: 10.1016/S2468-1253(25)00006-8